The hydrodynamics-based procedure for controlling the pharmacokinetics of gene medicines at whole body, organ and cellular levels.
about
Secreted luciferase for in vivo evaluation of systemic protein delivery in miceTransient expression of proteins by hydrodynamic gene delivery in mice.Establishment of an early liver fibrosis model by the hydrodynamics-based transfer of TGF-beta1 genePrevention of TGF-β-induced early liver fibrosis by a maleic acid derivative anti-oxidant through suppression of ROS, inflammation and hepatic stellate cells activation.Inhibition of tumour metastasis by targeted delivery of antioxidant enzymes.Pharmacokinetic considerations regarding non-viral cancer gene therapy.Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1.Hydrodynamic gene delivery and its applications in pharmaceutical research.Systemic in vivo delivery of siRNA to tumours using combination of polyethyleneimine and transferrin-polyethyleneimine conjugates.Dynamic morphological examination and evaluation of biological characteristics of a multinodular liver cancer model in mice.Saturation of transgene protein synthesis from mRNA in cells producing a large number of transgene mRNA.Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors.Inhibitory effects of interferon-gamma plasmid DNA on DMBA-TPA induced mouse skin carcinogenesis.Regulation of immunological balance by sustained interferon-γ gene transfer for acute phase of atopic dermatitis in mice.Role of recombinant plasmid pEGFP-N1-IGF-1 transfection in alleviating osteoporosis in ovariectomized rats.
P2860
Q33693031-2E59906C-4268-4A18-8889-488F0C7D4FBEQ34237207-1219EED2-39F6-4FEB-BFF2-CA768E30137EQ36183787-BE7202FC-B6CE-47DF-93C8-29438251B2BBQ36338112-A423FFFA-4EC3-4EBC-84A7-E6281B5C41D5Q36460852-07F94079-8B9F-4271-957E-4B8F6C9ED5CEQ37092309-5279A309-02A4-4AB6-8F2A-BB673D3D8707Q37111098-7B73BA1F-60DD-4FB2-9B14-855DC6F416A4Q37824615-15198500-457C-4630-B77B-2DE5535503A7Q38836715-B657C3BC-A573-4F2F-B92F-0D730C6AD99DQ39041013-11F7A679-7E04-4455-8021-B81EA2C698E3Q39552984-94B3BC64-572F-40FF-8008-D022B73D7422Q40269728-31BB1AA3-A0DE-493C-9AC3-CE7598237011Q45872192-224DBE68-93BA-4EF3-BE60-6E6BF2809B02Q45881327-2CED5EB3-95D5-41F3-80BD-239B4183C426Q45885836-1B801394-393B-4D4E-9D90-5C7D2619EB0F
P2860
The hydrodynamics-based procedure for controlling the pharmacokinetics of gene medicines at whole body, organ and cellular levels.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The hydrodynamics-based proced ...... dy, organ and cellular levels.
@ast
The hydrodynamics-based proced ...... dy, organ and cellular levels.
@en
type
label
The hydrodynamics-based proced ...... dy, organ and cellular levels.
@ast
The hydrodynamics-based proced ...... dy, organ and cellular levels.
@en
prefLabel
The hydrodynamics-based proced ...... dy, organ and cellular levels.
@ast
The hydrodynamics-based proced ...... dy, organ and cellular levels.
@en
P2093
P1476
The hydrodynamics-based proced ...... dy, organ and cellular levels.
@en
P2093
Makiya Nishikawa
Naoki Kobayashi
Yoshinobu Takakura
P304
P356
10.1016/J.ADDR.2004.12.006
P407
P577
2005-04-01T00:00:00Z